FDA approves inhalable diabetes drugMSN MoneyWASHINGTON (AP) – The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals. The FDA cleared MannKind Corp.’s drug Afrezza, a fast-acting form of …and more …Read Full Story
FDA approves inhalable diabetes drug - MSN Money
Real Estate of Cebu
